---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-017096"
form_type: "8-K"
ticker: null
cik: "0000876378"
company_name: "ASENSUS SURGICAL, INC."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:56:48.617771+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Asensus Surgical receives non-binding acquisition proposal from KARL STORZ at $0.35/share; Q1 revenue $1.1M

## Summary
- KARL STORZ proposes to acquire 100% of Asensus for $0.35/share cash; 10-week exclusivity period for due diligence.
- KARL STORZ provides up to $20M secured loan; $7M drawn to date to support operations during exclusivity.
- Q1 2024 revenue $1.1M (vs $1.0M Q1 2023); net loss $22.5M ($0.08 loss per share).
- Cash and short-term investments $8.0M at March 31, 2024; low liquidity position.
- Nearly 900 procedures performed globally in Q1; one new Senhance program initiated YTD.

## SEC filing metadata
- accession: 0001437749-24-017096
- form_type: 8-K
- cik: 0000876378
- company_name: ASENSUS SURGICAL, INC.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/0001437749-24-017096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/asxc20240514_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-017096
- JSON: https://secwatch.observer/filing/0001437749-24-017096.json
- Plain text: https://secwatch.observer/filing/0001437749-24-017096.txt

## Key facts
- Earnings Releases
  ASENSUS SURGICAL, INC. reported the first quarter ended March 31, 2024 results: revenue $1.1 million, net income $22.5 million, EPS $0.08 per share.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $1.1 million
  - Net income: $22.5 million
  - EPS: $0.08 per share
  - Result: reported results
  source text: For the three months ended March 31, 2024, the Company reported revenue of $1.1 million as compared to revenue of $1.0 million in the three months ended March 31, 2023. Revenue in the first quarter of 2024 included $0.5 million in lease revenue, $0.3 million in instruments and accessories, and $0.3 million in services. For the three months ended March 31, 2024, total operating expenses were $22.7 million, as compared to $20.4 million, in the three months ended March 31, 2023. For the three months ended March 31, 2024, net loss was $22.5 million, or $0.08 per share, as compared to a net loss of $22.2 million, or $0.09 per share, in the three months ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/0001437749-24-017096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.